Logo image of CTRE

CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

USA - NYSE:CTRE - US14174T1079 - REIT

34.45 USD
-0.35 (-1.01%)
Last: 9/29/2025, 1:01:01 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CTRE. CTRE was compared to 129 industry peers in the Diversified REITs industry. While CTRE has a great profitability rating, there are some minor concerns on its financial health. CTRE is growing strongly while it is still valued neutral. This is a good combination! With these ratings, CTRE could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CTRE was profitable.
CTRE had a positive operating cash flow in the past year.
CTRE had positive earnings in 4 of the past 5 years.
CTRE had a positive operating cash flow in each of the past 5 years.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

CTRE has a better Return On Assets (4.71%) than 92.25% of its industry peers.
With a decent Return On Equity value of 6.64%, CTRE is doing good in the industry, outperforming 77.52% of the companies in the same industry.
The Return On Invested Capital of CTRE (4.38%) is better than 80.62% of its industry peers.
CTRE had an Average Return On Invested Capital over the past 3 years of 5.24%. This is above the industry average of 3.04%.
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROIC 4.38%
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

CTRE has a better Profit Margin (58.73%) than 97.67% of its industry peers.
In the last couple of years the Profit Margin of CTRE has grown nicely.
CTRE has a better Operating Margin (66.50%) than 99.22% of its industry peers.
CTRE's Operating Margin has improved in the last couple of years.
CTRE's Gross Margin of 98.44% is amongst the best of the industry. CTRE outperforms 98.45% of its industry peers.
Industry RankSector Rank
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRE is destroying value.
CTRE has more shares outstanding than it did 1 year ago.
CTRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTRE has been reduced compared to a year ago.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 3.57 indicates that CTRE is not in any danger for bankruptcy at the moment.
CTRE's Altman-Z score of 3.57 is amongst the best of the industry. CTRE outperforms 97.67% of its industry peers.
CTRE has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.35, CTRE belongs to the best of the industry, outperforming 96.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 3.57
ROIC/WACC0.51
WACC8.58%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.75 indicates that CTRE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.75, CTRE is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
CTRE has a Quick Ratio of 1.75. This is a normal value and indicates that CTRE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.75, CTRE is doing good in the industry, outperforming 74.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.47%, which is quite impressive.
CTRE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.30% yearly.
Looking at the last year, CTRE shows a very strong growth in Revenue. The Revenue has grown by 50.83%.
Measured over the past years, CTRE shows a quite strong growth in Revenue. The Revenue has been growing by 12.64% on average per year.
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%102.99%

3.2 Future

The Earnings Per Share is expected to grow by 25.19% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.83% on average over the next years. This is a very strong growth
EPS Next Y75.39%
EPS Next 2Y37.28%
EPS Next 3Y25.19%
EPS Next 5YN/A
Revenue Next Year40.34%
Revenue Next 2Y33.46%
Revenue Next 3Y27.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.01 indicates a quite expensive valuation of CTRE.
Based on the Price/Earnings ratio, CTRE is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.54. CTRE is around the same levels.
The Price/Forward Earnings ratio is 22.29, which indicates a rather expensive current valuation of CTRE.
CTRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CTRE is cheaper than 88.37% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CTRE to the average of the S&P500 Index (23.05), we can say CTRE is valued inline with the index average.
Industry RankSector Rank
PE 28.01
Fwd PE 22.29
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRE is valued more expensive than 92.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.19
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CTRE may justify a higher PE ratio.
A more expensive valuation may be justified as CTRE's earnings are expected to grow with 25.19% in the coming years.
PEG (NY)0.37
PEG (5Y)2.48
EPS Next 2Y37.28%
EPS Next 3Y25.19%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.91%, CTRE has a reasonable but not impressive dividend return.
CTRE's Dividend Yield is slightly below the industry average, which is at 6.41.
Compared to an average S&P500 Dividend Yield of 2.41, CTRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.91%

5.2 History

The dividend of CTRE has a limited annual growth rate of 4.05%.
CTRE has paid a dividend for at least 10 years, which is a reliable track record.
CTRE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.05%
Div Incr Years9
Div Non Decr Years9
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CTRE pays out 96.62% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CTRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP96.62%
EPS Next 2Y37.28%
EPS Next 3Y25.19%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (9/29/2025, 1:01:01 PM)

34.45

-0.35 (-1.01%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners89.46%
Inst Owner Change8.37%
Ins Owners0.47%
Ins Owner Change1.14%
Market Cap7.69B
Analysts87.14
Price Target36.85 (6.97%)
Short Float %2.94%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 3.91%
Yearly Dividend1.09
Dividend Growth(5Y)4.05%
DP96.62%
Div Incr Years9
Div Non Decr Years9
Ex-Date09-30 2025-09-30 (0.335)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.16%
Min EPS beat(2)-6.76%
Max EPS beat(2)0.43%
EPS beat(4)2
Avg EPS beat(4)-8.38%
Min EPS beat(4)-29.49%
Max EPS beat(4)2.3%
EPS beat(8)2
Avg EPS beat(8)-24.52%
EPS beat(12)2
Avg EPS beat(12)-38.92%
EPS beat(16)4
Avg EPS beat(16)-30.02%
Revenue beat(2)1
Avg Revenue beat(2)9.81%
Min Revenue beat(2)-15.93%
Max Revenue beat(2)35.56%
Revenue beat(4)2
Avg Revenue beat(4)10.79%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)35.56%
Revenue beat(8)4
Avg Revenue beat(8)5.96%
Revenue beat(12)7
Avg Revenue beat(12)4.33%
Revenue beat(16)8
Avg Revenue beat(16)2.79%
PT rev (1m)3.58%
PT rev (3m)11.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.31%
EPS NY rev (1m)0.12%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.53%
Revenue NY rev (1m)0.91%
Revenue NY rev (3m)2.37%
Valuation
Industry RankSector Rank
PE 28.01
Fwd PE 22.29
P/S 20.6
P/FCF N/A
P/OCF 24.45
P/B 2.33
P/tB 2.33
EV/EBITDA 27.19
EPS(TTM)1.23
EY3.57%
EPS(NY)1.55
Fwd EY4.49%
FCF(TTM)-5.04
FCFYN/A
OCF(TTM)1.41
OCFY4.09%
SpS1.67
BVpS14.78
TBVpS14.78
PEG (NY)0.37
PEG (5Y)2.48
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROCE 5.54%
ROIC 4.38%
ROICexc 4.7%
ROICexgc 4.7%
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
FCFM N/A
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
ROICexc(3y)5.66%
ROICexc(5y)5.62%
ROICexgc(3y)5.66%
ROICexgc(5y)5.62%
ROCE(3y)6.63%
ROCE(5y)6.75%
ROICexcg growth 3Y-3.12%
ROICexcg growth 5Y0.18%
ROICexc growth 3Y-3.12%
ROICexc growth 5Y0.18%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA 3.64
Cap/Depr 2097.02%
Cap/Sales 385.9%
Interest Coverage 8.55
Cash Conversion 99.23%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 3.57
F-Score5
WACC8.58%
ROIC/WACC0.51
Cap/Depr(3y)658.62%
Cap/Depr(5y)503.99%
Cap/Sales(3y)134.69%
Cap/Sales(5y)112.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
EPS Next Y75.39%
EPS Next 2Y37.28%
EPS Next 3Y25.19%
EPS Next 5YN/A
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%102.99%
Revenue Next Year40.34%
Revenue Next 2Y33.46%
Revenue Next 3Y27.83%
Revenue Next 5YN/A
EBIT growth 1Y56.55%
EBIT growth 3Y21.72%
EBIT growth 5Y16.53%
EBIT Next Year182.97%
EBIT Next 3Y56.82%
EBIT Next 5Y39.97%
FCF growth 1Y-2758.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.86%
OCF growth 3Y15.9%
OCF growth 5Y14.1%